Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease

Journal of AAPOS

Volumn 12, Issue 3, 2008, Pages 309-311

  Çakir, Mehmet ^a   Çekiç, Osman ^a   Yilmaz, Ö Faruk ^a  

^a Beyoglu Eye Research and Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BEVACIZUMAB; PEGAPTANIB; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CASE REPORT; CATARACT; CHILDHOOD DISEASE; DISEASE COURSE; DRUG EFFECT; DRUG POTENTIATION; EXUDATIVE RETINITIS; FLUORESCENCE ANGIOGRAPHY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINITIS; TELANGIECTASIA; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; RETINAL NEOVASCULARIZATION; TELANGIECTASIS; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 45449108608     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2008.01.009     Document Type: Article

References (4)

1. Shields J.A., Shields C.L., Honavar S.G., and Demirci H. Clinical variations and complications of Coats disease in 150 cases: The 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol 131 (2001) 561-571
2. Shields J.A., Shields C.L., Honavar S.G., Demirci H., and Cater J. Classification and management of Coats disease: The 2000 Proctor Lecture. Am J Ophthalmol 131 (2001) 572-583
3. Sun Y., Jain A., and Moshfeghin D.M. Elevated vascular endothelial growth factor levels in Coats disease: Rapid response to pegaptanib sodium. Graefe's Arch Clin Exp Ophthalmol 245 (2007) 1387-1388
4. Silodor J.J., Augsburger J.A., Shields J.A., and Tasman W. Natural history and management of advanced Coat's disease. Ophthalmic Surg 19 (1988) 89-93